S'abonner

Impact of Early-Onset Sepsis and Antibiotic Use on Death or Survival with Neurodevelopmental Impairment at 2 Years of Age among Extremely Preterm Infants - 20/05/20

Doi : 10.1016/j.jpeds.2020.02.038 
Sagori Mukhopadhyay, MD, MMSc 1, 2, , Karen M. Puopolo, MD, PhD 1, 2, Nellie I. Hansen, MPH 3, Scott A. Lorch, MD, MSCE 1, 2, Sara B. DeMauro, MD, MSCE 1, 2, Rachel G. Greenberg, MD, MB, MHS 4, C. Michael Cotten, MD, MHS 4, Pablo J. Sánchez, MD 5, Edward F. Bell, MD 6, Eric C. Eichenwald, MD 1, 2, Barbara J. Stoll, MD 7
on behalf of the

Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network

  List of additional members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network is available at www.jpeds.com (Appendix).

1 Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia 
2 Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 
3 Social, Statistical and Environmental Sciences Unit, RTI International, Research Triangle Park, NC 
4 Department of Pediatrics, Duke University, Durham, NC 
5 Neonatology and Pediatric Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University College of Medicine, The Center for Perinatal Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 
6 Department of Pediatrics, University of Iowa, Iowa City, IA 
7 Department of Pediatrics, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 

Reprint requests: Sagori Mukhopadhyay, MD, MMSc, The Children's Hospital of Philadelphia Newborn Care at Pennsylvania Hospital, 800 Spruce St, Philadelphia, PA 19107.The Children's Hospital of Philadelphia Newborn Care at Pennsylvania Hospital800 Spruce StPhiladelphiaPA19107

Abstract

Objective

To evaluate the hypothesis that early-onset sepsis increases risk of death or neurodevelopmental impairment (NDI) among preterm infants; and that among infants without early-onset sepsis, prolonged early antibiotics alters risk of death/NDI.

Study design

Retrospective cohort study of infants born at the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers (2006-2014) at 22-26 weeks of gestation and birth weight 401-1000 g. Early-onset sepsis defined as growth of a pathogen from blood or cerebrospinal fluid culture ≤72 hours after birth. Prolonged early antibiotics was defined as antibiotics initiated ≤72 hours and continued ≥5 days without culture-confirmed infection, necrotizing enterocolitis, or spontaneous perforation. Primary outcome was death before follow-up or NDI assessed at 18-26 months corrected age. Poisson regression was used to estimate adjusted relative risk (aRR) and CI for early-onset sepsis outcomes. A propensity score for receiving prolonged antibiotics was derived from early clinical factors and used to match infants (1:1) with and without prolonged antibiotic exposure. Log binomial models were used to estimate aRR for outcomes in matched infants.

Results

Among 6565 infants, those with early-onset sepsis had higher aRR (95% CI) for death/NDI compared with infants managed with prolonged antibiotics (1.18 [1.06-1.32]) and to infants without prolonged antibiotics (1.23 [1.10-1.37]). Propensity score matching was achieved for 4362 infants. No significant difference in death/NDI (1.04 [0.98-1.11]) was observed with or without prolonged antibiotics among the matched cohort.

Conclusions

Early-onset sepsis was associated with increased risk of death/NDI among extremely preterm infants. Among matched infants without culture-confirmed infection, prolonged early antibiotic administration was not associated with death/NDI.

Le texte complet de cet article est disponible en PDF.

Keywords : prolonged early antibiotics, culture-negative infection

Abbreviations : aRR, AUR, BW, CSF, LOS, IVH, NDI, NEC, NRN, PS, SIP


Plan


 Funding and disclosure information available at www.jpeds.com.


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 221

P. 39 - juin 2020 Retour au numéro
Article précédent Article précédent
  • 50 Years Ago in The Journal of Pediatrics : Developmental Outcome for Trisomy 21 Mosaicism
  • Jannicke H. Andresen, Ola Didrik Saugstad
| Article suivant Article suivant
  • Maternal Instruction About Jaundice and the Incidence of Acute Bilirubin Encephalopathy in Nigeria
  • Richard P. Wennberg, Stephen Oguche, Zainab Imam, Zubaida L. Farouk, Isa Abdulkadir, Paul D. Sampson, Tina M. Slusher, Fidelia Bode-Thomas, Bose O. Toma, Christopher S. Yilgwan, David Shwe, Akinyemi O. Ofakunrin, Udochukwu M. Diala, Chris Isichei, Victor Pam, Zuwaira Hassan, Shehu U. Abdullahi, Fatima Usman, Binta W. Jibir, Idris Y. Mohammed, Hadiza A. Usman, Muhammed Abdusalam, Aisha Kuliya-Gwarzo, Fatima I. Tsiga-Ahmad, Laila Umar, William N. Ogala, Fatimatu Abdullahi, Laila Hassan, Saratu Purdue, Troy Lund, Carlos D. Coda-Zabetta

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.